KRYS

KRYSTAL BIOTECH INC

Healthcare | Mid Cap

$1.50

EPS Forecast

$114.3

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31T00:00:00 soon
CRBUCaribou Biosciences IncBDTXBlack Diamond Therapeutics IncCHRSCoherus Oncology IncALGSAligos Therapeutics IncGLUEMonte Rosa Therapeutics IncTSHATaysha Gene Therapies Inc